D9128 Dental Code: Photobiomodulation Therapy Billing Guide

What D9128 covers and does not cover

D9128 reports the first 15-minute increment of photobiomodulation (PBM) therapy performed in a dental setting. Photobiomodulation is the application of specific wavelengths of light (typically red or near-infrared, 600 to 1000 nm) at low power densities to tissue. The therapy promotes cellular repair, reduces inflammation, and modulates pain signaling. The code is not limited to a single clinical indication. It applies to any intraoral or perioral PBM application where the dentist provides the therapy for a therapeutic purpose.

It does not cover:

• Additional time beyond the first 15 minutes. Use D9129 for each additional 15-minute increment.
• Diagnostic use of lasers (caries detection, fluorescence imaging). Those fall under the diagnostic code family.
• Soft-tissue laser surgery (gingivectomy, frenectomy, incision and drainage). Those are coded under the oral surgery or periodontic families depending on the procedure.
• Hard-tissue laser procedures (cavity preparation, crown lengthening with laser). Those are coded by the procedure performed, not the tool used.
• Cosmetic light-based treatments (teeth whitening with LED activation). Whitening has its own codes.

D9128 is about therapeutic light application at sub-thermal power levels. If the laser is cutting, ablating, or curing, the procedure is something else.

When to bill D9128

Bill D9128 when:

• PBM therapy is performed as a distinct therapeutic step for a documented clinical indication.
• The treatment session is at least 15 minutes of actual light application to tissue.
• The therapy is performed by or under the supervision of the treating dentist.

Do not bill D9128 for:

• Setup time, patient positioning, or equipment calibration. The 15-minute increment starts when the light is applied to tissue.
• Laser use that is incidental to another coded procedure (e.g., a soft-tissue laser used during a gingivectomy that is already coded as D4210).
• Sessions shorter than 15 minutes where the intent is casual or incidental light exposure rather than a defined PBM protocol.

Clinical applications in dentistry

PBM has a growing evidence base across several dental applications. The most common clinical scenarios where D9128 applies:

• Post-extraction healing. Applied to the extraction site to reduce inflammation and accelerate socket healing. Often paired with D7140 (simple extraction) or D7210 (surgical extraction).
• Post-implant placement. Applied around the implant site to support osseointegration and reduce post-operative discomfort.
• Post-periodontal surgery. Applied after scaling and root planing (D4341/D4342) or flap surgery to promote soft-tissue healing.
• TMJ pain management. Applied to the temporomandibular joint area to reduce inflammation and modulate pain. This is also a candidate for medical cross-coding.
• Oral mucositis management. Applied to mucositis lesions, particularly in patients undergoing cancer therapy. One of the stronger evidence-based applications.
• Aphthous ulcer treatment. Applied to recurrent aphthous ulcers to reduce pain and healing time.
• Post-orthodontic pain. Applied after orthodontic adjustments to reduce discomfort. Less commonly billed but clinically documented.
• Nerve regeneration. Applied in cases of paresthesia following third molar extraction or implant placement to support nerve recovery.

The clinical indication drives the billing justification. “We own a PBM device” is not a billing reason. The chart must document the specific condition being treated and why PBM was appropriate for that patient.

D9128 and D9129: first increment versus additional increments

D9128 covers the first 15-minute increment of PBM therapy. D9129 covers each subsequent 15-minute increment, or any portion thereof. That last phrase is in both official descriptors, and it changes how the codes work: D9129 becomes reportable the moment treatment crosses past the first 15 minutes into a second increment. A partial second increment is billable. The two codes are designed to work together, similar to the time-based structure used in anesthesia and sedation codes.

Billing by elapsed treatment time:

• 1 to 15 minutes: D9128 x 1.
• 15:01 to 30:00: D9128 x 1, D9129 x 1.
• 30:01 to 45:00: D9128 x 1, D9129 x 2.
• 45:01 to 60:00: D9128 x 1, D9129 x 3.

Each new 15-minute band adds one D9129 unit, and a band that is only partially entered still counts because of the “or any portion thereof” language. The time must reflect actual light-on-tissue treatment, not total chair time. If a 30-minute appointment includes 10 minutes of setup, 15 minutes of treatment, and 5 minutes of cleanup, that is one unit of D9128. Not two codes. Carriers may still apply their own time or unit edits, so verify per plan.

Document the start and end times of light application in the chart. If a carrier questions the number of units, the time log is the supporting evidence.

New code, carrier lag: the 2026 reality

D9128 is brand new in CDT 2026. Based on how prior new-code cycles have played out, here is what to expect:

Year one (2026): Most commercial carriers have not added D9128 to their fee schedules or coverage tables. Claims submitted with D9128 will return one of several responses: “code not recognized,” “not a covered benefit,” “experimental/investigational,” or simply process at $0 allowed. A small number of carriers may begin mapping the code to an adjunctive-services benefit category, but widespread adoption is unlikely before 2027.

What this means for the front desk: Quote PBM therapy as a patient-pay service unless you have confirmed coverage with the specific carrier. Do not estimate insurance coverage based on the existence of a CDT code. Having a code and having coverage are two different things.

What this means for billing: Submit the claim with D9128 anyway, even when you expect denial. Submitting establishes a utilization record with the carrier. Over time, carrier coverage decisions are influenced by claim volume. If no one bills the code, carriers have no data to build a coverage policy around.

The “experimental/investigational” exclusion

The most common denial reason for D9128 will not be “code not recognized.” It will be “experimental or investigational procedure.” This denial is harder to appeal than a simple code-recognition issue because it comes from the plan’s contract language, not from the carrier’s claims system.

Here is the distinction:

• Code not recognized: The carrier’s system hasn’t been updated for CDT 2026. This resolves over time as carriers update their code tables. You can call the carrier, reference the ADA’s CDT 2026 code list, and request a manual review.
• Experimental/investigational: The plan’s benefit contract explicitly excludes procedures the carrier classifies as experimental. Even though the ADA has published a CDT code for PBM, the carrier’s medical/dental policy committee may not have reviewed the evidence and moved PBM out of the “experimental” category.

Appealing an experimental exclusion requires clinical evidence. If you pursue it, include peer-reviewed studies supporting PBM for the specific indication (post-surgical healing, mucositis, TMJ). The ADA’s recognition of the code in CDT 2026 is a supporting data point but not dispositive. Carriers make independent coverage determinations.

For most practices in 2026, the practical approach is to bill PBM as a patient-pay service, submit the insurance claim for the utilization record, and revisit coverage annually as carrier policies evolve.

Documentation that supports the claim

Even when the service is patient-pay, document PBM therapy in full. If a carrier audits or if coverage becomes available retroactively, the chart must support the service.

The claim needs:

• Date of service.
• D9128 (and D9129 if applicable, with units).
• The procedure code for any associated dental procedure performed on the same date.

For the patient record, document:

• Clinical indication. Why PBM was performed (e.g., post-extraction inflammation, TMJ pain, aphthous ulcer).
• Wavelength. The specific wavelength in nanometers (e.g., 810 nm, 660 nm).
• Power density. Milliwatts per square centimeter (mW/cm2).
• Total energy delivered. Joules per square centimeter (J/cm2) if your device tracks this.
• Duration. Actual light-on-tissue time in minutes, with start and end times.
• Area treated. Anatomic description (e.g., “buccal and lingual mucosa surrounding extraction site #30”).
• Treatment protocol. Continuous vs. pulsed, distance from tissue, number of points treated.

This level of detail also protects the practice if a patient disputes the charge or if state board questions arise about the appropriateness of the therapy.

Example case

A 52-year-old patient undergoes surgical extraction of an impacted lower left third molar (tooth #17, D7210). The surgeon applies PBM therapy to the extraction site right after closure to reduce inflammation and promote healing. The PBM session lasts 18 minutes of light application using an 810 nm diode laser at 200 mW/cm2.

Treatment sequence:

1. Surgical extraction completed. Site irrigated and sutured.
2. PBM device positioned. 810 nm wavelength, 200 mW/cm2, continuous mode.
3. Light application begins at 10:42 AM. Applied to buccal mucosa, lingual mucosa, and directly over the extraction socket in a slow-scanning pattern.
4. Light application ends at 11:00 AM. Total treatment time: 18 minutes.
5. Post-op instructions given. Patient discharged.

Billing steps:

1. The patient’s plan does not cover PBM. Quote the D9128 fee as patient-pay before the procedure. Collect at time of service.
2. Submit on the date of service:
   • D7210 on tooth #17 (to insurance).
   • D9128 x 1 (to insurance, expecting denial or $0 payment).
   • D9129 x 1 (to insurance). The session was 18 minutes: one full 15-minute increment plus 3 minutes into a second. Because D9129’s descriptor reads “each subsequent 15-minute increment, or any portion thereof,” those 3 minutes are a reportable portion, so D9129 x 1 applies. A carrier may still apply a time or unit edit and deny it, which on a PBM claim in 2026 is the likely outcome regardless.
3. If the carrier denies D9128 as experimental, note the denial in the carrier record for future reference. No appeal is cost-effective in this scenario unless the practice is building a systematic case for coverage with that carrier.
4. If the carrier unexpectedly pays, post the payment and refund the patient the covered portion.

What to get right in your PMS

The exact menus and field names vary across Open Dental, Dentrix, Eaglesoft, Curve, and Carestream. The steps that matter:

1. Add D9128 and D9129 to your procedure code table. These are new 2026 codes. If your PMS received the CDT 2026 update, verify the codes are active. If not, add them manually with the correct code, description, and your office fee.
2. Set a fee for both codes. PBM is almost always patient-pay in 2026. Your fee schedule needs a posted fee for D9128 and D9129 that reflects the practice’s costs (device amortization, consumables, provider time) and local market.
3. Post D9128 on the date the therapy is performed, paired with the associated procedure. The PBM code goes on the same claim as the extraction, implant, or other procedure it supports.
4. Record treatment time in the clinical note. A PBM-specific note template with fields for wavelength, power density, duration, area treated, and indication saves time and ensures nothing is missed.
5. Track carrier responses on D9128 separately. Over 2026 and 2027, some carriers will begin recognizing the code. A note on the carrier record (“D9128 denied as experimental, 3/2026” or “D9128 paid at $X, 6/2026”) helps the front desk quote accurately.

If your practice is adding PBM therapy for the first time in 2026, the billing setup takes about ten minutes per code. The harder part is setting patient expectations: this is a real therapy with a real CDT code, and the patient will pay out of pocket until carriers catch up.